JPH0928762A - Holder for medicine container connected to medical container - Google Patents

Holder for medicine container connected to medical container

Info

Publication number
JPH0928762A
JPH0928762A JP7203862A JP20386295A JPH0928762A JP H0928762 A JPH0928762 A JP H0928762A JP 7203862 A JP7203862 A JP 7203862A JP 20386295 A JP20386295 A JP 20386295A JP H0928762 A JPH0928762 A JP H0928762A
Authority
JP
Japan
Prior art keywords
container
lid
holder
drug
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP7203862A
Other languages
Japanese (ja)
Inventor
Tatsuo Suzuki
龍夫 鈴木
Keinosuke Isono
啓之介 磯野
Hiroshi Motobayashi
博志 本林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Material Engineering Technology Laboratory Inc
Original Assignee
Material Engineering Technology Laboratory Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Material Engineering Technology Laboratory Inc filed Critical Material Engineering Technology Laboratory Inc
Priority to JP7203862A priority Critical patent/JPH0928762A/en
Publication of JPH0928762A publication Critical patent/JPH0928762A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

PROBLEM TO BE SOLVED: To easily perform disinfection variably at a connection part and to maintain a sterilized state for a long time by mounting a cover on a housing member in a state where the cover is pressed on a medicine container. SOLUTION: This holder 1 is provided with the connection part 15 connected to a medicine container 2, and also, holds a medicine vial 5 connected by communication with the medicine container 2. Moreover, the holder 1 is provided with the housing member 11 formed integrally with the connection part 15 communicated with a housing part where the medicine vial 5 is housed and whose inside is kept in the sterilized state. The cover 12 is attached to the housing member 11 so as to press the medicine vial 5 toward an elastic cushioning member 13. The medicine vial 5 is formed so as to cover the communication port 14 of the housing part and the connection part via the elastic cushioning member 13. Also, the medicine container 2 using such holder 1 is formed with an unfixed-form flexible resin container.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、医療用容器に接続され
る薬剤容器のホルダーに関するものであり、より詳細に
は直前に二以上の薬剤を無菌的に調整して使用する場合
における連通部或いは接続部を備えた医療用容器に接続
される薬剤容器のホルダーに関するものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a holder for a drug container to be connected to a medical container, and more particularly, to a communicating part when aseptically adjusting two or more drugs immediately before use. Alternatively, the present invention relates to a holder for a drug container that is connected to a medical container having a connecting portion.

【0002】[0002]

【従来の技術】点滴注射に用いられる輸液等のバック、
コンテナ等の医療用容器は、一般に樹脂容器である。ま
た医療用容器には、抗生物質等の高圧蒸気滅菌ができな
い薬剤のバイアル等を接続するものや、使用直前まで薬
液を分けて保存した薬液容器を使用時に接続又は連通す
るものがある。更に、予め医療用容器と薬剤バイアル等
を接続可能な状態にさせたものがあり、その薬剤容器と
医療用容器本体との連通部が滅菌処理してある薬剤キッ
ト等の提案がある。
2. Description of the Related Art Bags for infusions and the like used for intravenous injection,
Medical containers such as containers are generally resin containers. Some medical containers are connected to vials or the like of drugs such as antibiotics that cannot be sterilized by high-pressure steam, and some are connected or communicated during use with a liquid container in which the liquid is separately stored until just before use. Further, there is a proposal in which a medical container and a drug vial are made to be connectable in advance, and a drug kit and the like in which a communicating portion between the drug container and the medical container body is sterilized.

【0003】従来の薬剤キットは、実公平5−4283
3号公報に提案され、図7に示す如く、医療用容器70
の接続口70aに接続ポート72が取り付けられ、接続
ポート72の連通孔には連通針74が取り付けられ、連
通針74には液止めキャップ76が取り付けられる。ま
た、接続口70aの上方には薬剤バイアル78及びバイ
アルホルダー80が配せられ、薬剤バイアル78は下動
可能に設けられると共に、その下動時に口部のゴム栓体
82に連通針74が刺針される。バイアルホルダー80
は、収容カプセル84及び蓋86とからなり、収容カプ
セル84は接続ポート72に液密に連通する接続部84
aが形成される。蓋86は、外側に吊り下げ部86aが
形成され、内側にバイアル78を保持すると共に下動さ
せる保持機構88が設けられている。そして、保持機構
88はバイアル78の底部を保持している。また、収容
カプセル84、接続ポート72及び蓋86で仕切られる
チャンバー90は無菌が維持されなければならない。こ
のため、蓋86或いは収容カプセル84の一部はガス透
過性に形成され、エチレンオキサドガス滅菌などがなさ
れる。
[0003] The conventional drug kit is Jpn.
As disclosed in Japanese Patent Publication No. 3 and shown in FIG. 7, a medical container 70 is provided.
A connection port 72 is attached to the connection port 70 a of the above, a communication needle 74 is attached to a communication hole of the connection port 72, and a liquid stopper cap 76 is attached to the communication needle 74. Further, a drug vial 78 and a vial holder 80 are arranged above the connection port 70a, and the drug vial 78 is provided so as to be movable downward, and at the time of the downward movement, the communication needle 74 is inserted into the rubber stopper body 82 of the opening. To be done. Vial holder 80
Is composed of an accommodating capsule 84 and a lid 86, and the accommodating capsule 84 is connected to the connection port 72 in a liquid-tight connection portion 84.
a is formed. The lid 86 has a hanging portion 86a formed on the outer side, and a holding mechanism 88 for holding the vial 78 and moving it downward is provided on the inner side. The holding mechanism 88 holds the bottom of the vial 78. In addition, the chamber 90 partitioned by the encapsulation capsule 84, the connection port 72, and the lid 86 must be kept sterile. For this reason, the lid 86 or a part of the containing capsule 84 is formed to be gas permeable, and sterilized with ethylene oxide gas or the like.

【0004】このように構成された薬剤キットにおいて
は、蓋86が回転されることにより、ホルダー80内の
バイアル78が下動し、連通針74は、キャップ76を
突き破り、ゴム栓82が刺針される。これにより、医療
用容器70内とバイアル78内とが連通され、薬剤と溶
解液とが混合可能となる。この場合、ゴム栓82の外表
面が無菌維持されるためには上述の滅菌処理が十分に必
要とされる。
In the drug kit thus constructed, by rotating the lid 86, the vial 78 in the holder 80 moves downward, the communicating needle 74 pierces the cap 76, and the rubber plug 82 is punctured. It As a result, the inside of the medical container 70 and the inside of the vial 78 are communicated with each other, and the drug and the solution can be mixed. In this case, the above-mentioned sterilization treatment is sufficiently required to keep the outer surface of the rubber stopper 82 aseptic.

【0005】[0005]

【発明が解決しようとする課題】しかしながら、従来の
医療用容器に接続される薬剤容器のホルダーは以下の問
題点がある。収容カプセル84内の滅菌が必要される
が、カプセル84内の全体を滅菌する必要があるため、
カプセル内の薬剤に影響を与えずに滅菌しようとする
と、ガス滅菌などの限られた滅菌処理方法しか採用でき
ない。また、従来の収容カプセル84と蓋86との間
は、液密にしなければ保存時に滅菌が維持されない。こ
のため、蓋86には液密に保持するための弾性部材や特
殊な樹脂部材を使用する必要があり、組立が煩雑な他
に、これらの部材は一般に透明性がなく、使用時にホル
ダー80の外側から十分に薬剤の状態を監視することが
できない。
However, the conventional drug container holder connected to a medical container has the following problems. Although sterilization inside the containing capsule 84 is required, it is necessary to sterilize the entire inside of the capsule 84,
In order to sterilize without affecting the drug in the capsule, only a limited sterilization method such as gas sterilization can be adopted. In addition, sterilization is not maintained during storage unless the space between the conventional storage capsule 84 and the lid 86 is liquid-tight. For this reason, it is necessary to use an elastic member or a special resin member for holding the lid 86 in a liquid-tight manner, and in addition to complicated assembly, these members are generally not transparent and the holder 80 of the holder 80 is not used. Insufficient external monitoring of drug status.

【0006】また、ホルダー全体の滅菌を避け、接続部
の易滅菌を可能にした構造のものも提供されている。例
えば、医療用容器の接続部と薬剤容器のゴム栓体部分と
を加熱レジンで固めた接続方法を採用した薬剤キットで
ある(特公平3−73307号公報)。このような方法
は、接続部の滅菌が容易であっても、保存時にゴム栓体
部分とレジンとの間に隙間ができたり、またその製造工
程が容易ではないという問題がある。
There is also provided a structure in which the sterilization of the entire holder is avoided and the connection portion can be easily sterilized. For example, it is a drug kit that employs a connection method in which the connection part of the medical container and the rubber stopper part of the drug container are hardened with a heating resin (Japanese Patent Publication No. 3-73307). Even if such a method is easy to sterilize the connection portion, there is a problem that a gap is formed between the rubber plug portion and the resin during storage and the manufacturing process thereof is not easy.

【0007】従って、本発明の目的は、接続部での滅菌
が多様且つ簡単にでき、また接続部の長期間の無菌的維
持ができると共に、組立が簡単にできる医療用容器が接
続される薬剤容器のホルダーを提案することにある。ま
た、本発明の目的は、薬剤容器内の薬剤の混合状態を十
分に確認しながら混合操作ができる医療用容器が接続さ
れる薬剤容器のホルダーを提供することにある。
Therefore, an object of the present invention is to provide a medicine to which a medical container is connected, which allows various and simple sterilization at the connection part, can maintain the connection part aseptically for a long time, and can be easily assembled. To propose a container holder. Another object of the present invention is to provide a holder for a drug container to which a medical container that can be mixed while sufficiently checking the mixed state of the drug in the drug container is connected.

【0008】[0008]

【課題を解決するための手段】本発明は、医療用容器に
接続される接続部を有し、且つ該医療容器内と連通接続
される薬剤容器を保持するホルダーにおいて、上記薬剤
容器を収容する収容部内に連通して、内部が無菌的に維
持される上記接続部を有した収容部材と、上記収容部材
に取り付けられ、上記収容部と接続部との連通口を上記
薬剤容器の口部用弾性栓体で、或いは弾性部材を介して
覆っている該薬剤容器を該栓体或いは弾性部材に向けて
押圧する蓋体とからなることを特徴とする医療用容器に
接続される薬剤容器のホルダーを提供することにより、
上記目的を達成したものである。
SUMMARY OF THE INVENTION According to the present invention, a holder for holding a drug container which has a connecting portion connected to a medical container and is connected to communicate with the inside of the medical container accommodates the drug container. An accommodating member having the above-mentioned connecting portion that communicates with the inside of the accommodating portion and the inside of which is maintained aseptically, and a communication port between the accommodating portion and the connecting portion, which is attached to the accommodating member, is for the mouth portion of the drug container. A holder for a drug container connected to a medical container, characterized by comprising an elastic stopper or a lid for pressing the drug container covered via an elastic member toward the stopper or the elastic member. By providing
The above object has been achieved.

【0009】本発明に係るホルダーにおいて、上記収容
部材と蓋体とには互いに係合する係合部が形成され、該
係合部の係合により上記蓋体が上記薬剤容器を押圧して
上記収容部材に係着して取り付けられることを特徴とす
る。本発明に係るホルダーにおいて、上記収容部材及び
蓋体は、上記薬剤容器内の薬剤の認識可能な透明樹脂成
形物であることを特徴とする。本発明に係るホルダーに
おいて、上記蓋体は、ポリエチレン系樹脂成形物からな
り、該樹脂の引張強さ(JISK6760法:kgf/c
m2)が300kgf/cm2以下、引張破壊伸び(JISK6
760法:%)が90〜1000%の範囲であることを
特徴とする。本発明に係るホルダーにおいて、上記薬剤
容器を押圧する押圧面には突起リブが形成されることを
特徴とする。本発明に係るホルダーにおいて、上記蓋体
の側壁がテーパ形成され、上記薬剤容器の底部の周縁が
該テーパ側壁と当接して押圧された状態で配されている
ことを特徴とする。本発明に係るホルダーにおいて、上
記蓋体の側壁にはテーパ状の突起リブが形成され、上記
薬剤容器の底部の周縁が該突起リブと当接して押圧され
た状態で配されていることを特徴とする。
In the holder according to the present invention, an engaging portion that engages with each other is formed in the housing member and the lid, and the lid presses the drug container by the engagement of the engaging portion. It is characterized in that it is attached by being attached to the accommodation member. In the holder according to the present invention, the storage member and the lid are characterized by being a transparent resin molding capable of recognizing the medicine in the medicine container. In the holder according to the present invention, the lid is made of a polyethylene resin molded product, and has a tensile strength (JIS K6760 method: kgf / c).
m 2 ) is 300 kgf / cm 2 or less, tensile breaking elongation (JISK6
760 method:%) is in the range of 90 to 1000%. In the holder according to the present invention, a protruding rib is formed on the pressing surface that presses the medicine container. In the holder according to the present invention, the side wall of the lid is tapered, and the peripheral edge of the bottom portion of the drug container is arranged in a state of being pressed against the tapered side wall. In the holder according to the present invention, a tapered protrusion rib is formed on a side wall of the lid, and the peripheral edge of the bottom portion of the drug container is arranged in a state of being pressed against the protrusion rib. And

【0010】[0010]

【作用】本発明のホルダーにおいては、蓋体と収容部材
とは、蓋体が薬剤容器を押圧した状態で取り付けられて
いる。押圧した状態とは、薬剤容器の栓体或いは栓体に
密着して設けられる弾性部材を圧縮変形させて、蓋体が
収容部材に取り付けられている状態である。蓋体の押圧
に対して弾性部材はその弾性力を反力としている。そし
て、かかる弾性力は、上記接続部の連通口にもかかり、
薬剤容器の栓体或いは、弾性部材は上記収容部材の接続
部と薬剤容器本体の収容部とを完全に液密遮断する。こ
のため、従来のホルダーと異なり、接続部のみが滅菌さ
れ、また保存時に無菌的に維持できれば良いことにな
る。従って、接続部のみの滅菌を重点的にすれば良いた
め、薬剤に影響を与えずにγ線滅菌や易電子線滅菌や加
熱滅菌や過酸化水素処理などの化学滅菌などの多様な滅
菌方法を用いることができる。またホルダーは、収容部
材と蓋体との間を液密にシールする必要がないため、ホ
ルダーの収容部材と蓋体の取り付けを係合部による係着
とした場合、例えば、互いに係合するフック同士、或い
は突起部とそれに嵌着する係合孔等とした場合等のラフ
な取り付けが可能となる。このため、製造が煩雑で不透
明な螺合部材などを使用することがない。更に、薬剤容
器を下動させる機構もない。このため、収容部材及び蓋
体の全てを透明な樹脂成形物にすると、内部の薬剤の混
合状態を容易に把握することができる。
In the holder of the present invention, the lid and the accommodating member are attached with the lid pressing the drug container. The pressed state is a state in which the lid of the medicine container is attached to the accommodation member by compressing and deforming the elastic member provided close to the stopper or the stopper. The elastic member uses the elastic force as a reaction force against the pressing of the lid. Then, the elastic force is also applied to the communication port of the connection portion,
The stopper of the drug container or the elastic member completely liquid-tightly shuts off the connecting part of the containing member and the containing part of the drug container body. Therefore, unlike the conventional holder, only the connection part needs to be sterilized and can be maintained aseptically during storage. Therefore, since it is necessary to focus on sterilization of only the connection part, various sterilization methods such as γ-ray sterilization, easy electron beam sterilization, heat sterilization, and chemical sterilization such as hydrogen peroxide treatment can be performed without affecting the drug. Can be used. Further, since it is not necessary for the holder to liquid-tightly seal between the housing member and the lid, when the holder housing member and the lid are attached by the engaging portion, for example, hooks that engage with each other. Rough attachment is possible, for example, when the protrusions and the protrusions are engaged with each other or the engaging holes. For this reason, manufacturing is complicated and an opaque screw member or the like is not used. Further, there is no mechanism for moving the drug container downward. For this reason, if all of the housing member and the lid are made of a transparent resin molded product, the mixed state of the drug inside can be easily grasped.

【0011】また、上記薬剤容器、ホルダーの収容部
材、及び蓋体が正確な寸法で成形される場合は、栓体及
び弾性部材には常に一定した押圧力がかかり、弾性部材
等の劣化を考慮したとしても接続部の機密性が長期間維
持することができ、保存期間の安全性も高まる。しかし
ながら、薬剤容器、ホルダーの収容部材、及び蓋体の寸
法、特にガラス製の薬剤バイアルの寸法は、一定したも
のが提供されない場合がある。かかる場合、接続部での
機密性が失われ、最悪の場合は、所定の保存期間後に機
密性が失われることがあり、医療用容器としては問題と
なる。一方、弾性部材にかかる押圧力を強めに設定する
と、薬剤容器の寸法に微妙な誤差が生じると、弾性部材
に過大な押圧力がかかる。このため、弾性部材からの反
力が蓋体の押圧面に過剰にかかり、その結果、蓋体と収
容部材との組立が困難となり、生産ラインにおいても歩
留まりを悪くする。そこで、収容部材及び蓋体、特に蓋
体を汎用なポリエチレン系樹脂からなる樹脂成形物とし
て、その樹脂成形物の変形歪みを利用して弾性部材等に
かかる押圧を一定の範囲内となるようにすることができ
る。
Further, when the drug container, the holding member of the holder, and the lid are molded with accurate dimensions, a constant pressing force is always applied to the stopper and the elastic member, and deterioration of the elastic member or the like is considered. Even if it does, the confidentiality of the connection part can be maintained for a long period of time, and the safety of the storage period is improved. However, the dimensions of the drug container, the holding member of the holder, and the lid, particularly the size of the glass drug vial, may not be constant. In such a case, the confidentiality at the connection part may be lost, and in the worst case, the confidentiality may be lost after a predetermined storage period, which poses a problem as a medical container. On the other hand, if the pressing force applied to the elastic member is set to be relatively strong, an excessive pressing force is applied to the elastic member if a slight error occurs in the size of the drug container. Therefore, the reaction force from the elastic member is excessively applied to the pressing surface of the lid body, and as a result, it becomes difficult to assemble the lid body and the housing member, and the yield is deteriorated in the production line. Therefore, the accommodating member and the lid body, especially the lid body, are made of a general-purpose polyethylene resin so that the pressure applied to the elastic member or the like falls within a certain range by utilizing the deformation strain of the resin molded article. can do.

【0012】即ち、成形物のポリエチレン系樹脂は、引
張強さ(JISK6760法:kgf/cm2)が300kgf/c
m2以下、引張破壊伸び(JISK6760法:%)が9
0〜1000%の範囲にあると、薬剤バイアル等の寸法
が多少大きく、蓋体の押圧面が容器に当接したとき、弾
性部材等の反力が強すぎても、押圧面はある程度の形状
を保ちながら変形し、その反力が一定に成るように吸収
する。この場合、ポリエチレン系樹脂の引張強さが30
0kgf/cm2以下であれば、薬剤容器の寸法誤差を十分に
吸収することができる。また上記範囲を上回ると、蓋体
が変形するのにかなりの反力を要するため、弾性部材が
異常な圧縮変形を起こすおそれがある。また、樹脂の引
張破壊伸びが上記範囲内であれば、蓋体にある程度の変
形と伸びが生じて、寸法誤差がかかる変形及び伸びによ
り吸収され、弾性部材に対する押圧力が一定の範囲に収
めることができる。更に、蓋体の押圧面に突起リブが形
成されると、上記弾性部材に対する押圧の調整がリブの
高さ及びその変形等により決め細かくすることができ
る。また、蓋体の側壁をテーパ状にして薬剤容器をかか
る壁に当接させながら押圧すると、その壁面の変形が過
剰な反力の吸収となる。
That is, the polyethylene resin of the molded product has a tensile strength (JIS K6760 method: kgf / cm 2 ) of 300 kgf / c.
m 2 or less, tensile elongation at break (JISK 6760 method:%) is 9
In the range of 0 to 1000%, the size of the drug vial is somewhat large, and when the pressing surface of the lid comes into contact with the container, even if the reaction force of the elastic member is too strong, the pressing surface has a certain shape. It deforms while maintaining, and absorbs so that the reaction force becomes constant. In this case, the polyethylene resin has a tensile strength of 30.
If it is 0 kgf / cm 2 or less, the dimensional error of the drug container can be sufficiently absorbed. On the other hand, if it exceeds the above range, a considerable reaction force is required for the lid body to be deformed, so that the elastic member may be abnormally compressed and deformed. If the tensile breaking elongation of the resin is within the above range, the lid body will be deformed and stretched to some extent, and a dimensional error will be absorbed by the deformation and elongation, and the pressing force against the elastic member will be within a certain range. You can Further, when the protruding rib is formed on the pressing surface of the lid, the pressing of the elastic member can be finely adjusted by the height of the rib and its deformation. Further, when the side wall of the lid is tapered and the drug container is pressed while abutting against the wall, the deformation of the wall surface absorbs excessive reaction force.

【0013】[0013]

【実施例】以下、本発明に係るホルダーの好ましい実施
例を添付図面を参照しながら詳述する。図1は本発明に
係るホルダーの半断面図、図2は図1のホルダーの分解
側面図、図3は図1のホルダーにおける蓋体の接合面の
平面図、図4は図1のホルダーにおける収容部材の接合
面の平面図、図5は図1の使用中の要部の半断面図であ
る。
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS A preferred embodiment of the holder according to the present invention will be described below in detail with reference to the accompanying drawings. 1 is a half sectional view of a holder according to the present invention, FIG. 2 is an exploded side view of the holder of FIG. 1, FIG. 3 is a plan view of a joint surface of a lid in the holder of FIG. 1, and FIG. 4 is a view of the holder of FIG. FIG. 5 is a plan view of a joint surface of the housing member, and FIG. 5 is a half cross-sectional view of a main part in use of FIG. 1.

【0014】図1乃至図5に示す如く、本実施例のホル
ダー1は、医療用容器2に接続される接続部15を有
し、且つ該医療容器2内と連通接続される薬剤バイアル
5を保持する。そして、ホルダー1において、薬剤バイ
アル5を収容する収容部内と連通して内部が無菌的に維
持される接続部15を有した収容部材11と、収容部材
11に取り付けられ、弾性緩衝部材13を介して収容部
と接続部との連通口14を覆っている薬剤バイアル5を
弾性緩衝部材13に向けて押圧する蓋体12とからな
る。
As shown in FIGS. 1 to 5, the holder 1 of this embodiment has a connecting portion 15 connected to the medical container 2 and a drug vial 5 connected to the inside of the medical container 2 for communication. Hold. Then, in the holder 1, an accommodating member 11 having a connecting portion 15 which communicates with the accommodating portion for accommodating the drug vial 5 and the inside of which is maintained aseptically, and the accommodating member 11 which is attached to the accommodating member 11 and has an elastic cushioning member 13 And a lid 12 that presses the drug vial 5 that covers the communication port 14 between the housing portion and the connection portion toward the elastic cushioning member 13.

【0015】本実施例に係るホルダー1を更に詳しく説
明すると、先ず、ホルダー1が使用される医療用容器2
は、非定型性の柔軟な樹脂容器からなる。本実施例にお
いて具体的には、容器2は、低密度ポリエチレンをイン
フレーション成形により作製したチューブシートから形
成される。即ち、かかるシートが所定の長さに裁断さ
れ、その上下端が熱溶着により完全密着シールがされ
る。下端のシール部には、図1で図示しないが樹脂成形
物からなる排出口が熱溶着と共に取り付けられ、上端シ
ール部2Aには薬剤容器(薬剤バイアル)5との接続口
4が取り付けられて製造される。
The holder 1 according to this embodiment will be described in more detail. First, the medical container 2 in which the holder 1 is used.
Consists of an atypical, flexible resin container. Specifically, in this embodiment, the container 2 is formed of a tube sheet made of low density polyethylene by inflation molding. That is, such a sheet is cut into a predetermined length, and the upper and lower ends thereof are heat-welded to complete a tight seal. Although not shown in FIG. 1, a discharge port made of a resin molded product is attached to the lower end seal part together with heat welding, and a connection port 4 for connecting a drug container (drug vial) 5 is attached to the upper end seal part 2A. To be done.

【0016】図1に示す如く、接続口4は、接続口パイ
プ4A、連通針4B及び止め部材4Cからなる。接続口
パイプ4Aは、先端を薄肉膜41で閉止したスリーブ部
分が形成され、その基端部分44が熱シールにより液密
に容器2に固着される。連通針4Bは棒状の中空部材で
あり、先端が上記接続口パイプ4A内に挿入され、基端
が容器本体2内に位置した状態で配される。連通針4B
の先端には接続口パイプ4Aの薄肉膜41を貫通しうる
刺針部45が形成されると共に、連通針4Bの中空部と
連通する流通口46、46が形成される。また連通針4
Bの基端には、容器本体2外から連通針4Bを移動操作
する際に指等のかかりを良くする肉厚フランジ部47が
形成される。
As shown in FIG. 1, the connection port 4 comprises a connection port pipe 4A, a communication needle 4B and a stopper member 4C. The connection port pipe 4A is formed with a sleeve portion whose tip is closed by a thin film 41, and a base end portion 44 thereof is liquid-tightly fixed to the container 2 by heat sealing. The communication needle 4B is a rod-shaped hollow member, and the distal end is inserted into the connection port pipe 4A, and the proximal end is arranged in the container body 2. Communication needle 4B
A puncture portion 45 capable of penetrating the thin film 41 of the connection port pipe 4A is formed at the tip of, and flow ports 46, 46 communicating with the hollow portion of the communication needle 4B are formed. Communication needle 4
At the base end of B, a thick flange portion 47 is formed to improve the grip of a finger or the like when moving the communicating needle 4B from the outside of the container body 2.

【0017】容器本体2には、排出口及び接続口4が熱
シールにより取り付けられた後、排出口から溶解液3が
充填され、ゴム栓で排出口を封止した後、高圧蒸気滅菌
される。尚、安全性が保証されれば、無菌充填でも良
い。溶解液3は輸液用の基本投与物であり、後述する薬
剤容器5内の薬剤6を溶解、希釈或は混合等するもので
ある。具体的には、アミノ酸液、グルコースが主体の高
カロリー輸液の基本液、生理食塩水、5%ブドウ糖液、
注射用蒸留水のほか、各種電解質を含む溶液等が用いら
れる。高圧蒸気滅菌処理は、局方の高圧蒸気滅菌方法に
基づいて行われる。
After the discharge port and the connection port 4 are attached to the container body 2 by heat sealing, the solution 3 is filled from the discharge port, the discharge port is sealed with a rubber stopper, and then high-pressure steam sterilization is performed. . If safety is assured, aseptic filling may be used. The solution 3 is a basic administration material for infusion, and dissolves, dilutes, or mixes a drug 6 in a drug container 5 described later. Specifically, amino acid solution, basic solution for glucose-based high calorie infusion, physiological saline, 5% glucose solution,
In addition to distilled water for injection, solutions containing various electrolytes are used. The high-pressure steam sterilization process is performed based on the high-pressure steam sterilization method of the Japanese Pharmacopoeia.

【0018】薬剤容器5は、ガラスバイアルである。但
し、本実施例のようにガラス製とする必要はなく、その
素材が低密度ポリエチレン、高密度ポリエチレン、及び
ポリプロピレン等を組成物とした樹脂成形物でも良い。
薬剤容器5に第二成分である薬剤6が凍結乾燥により、
無菌的に充填されて口部がゴム栓7で密栓されて無菌的
に維持される。本実施例では第二成分の薬剤6は粉末の
抗性物質である。しかし、本実施例にあっては、薬剤7
を粉末に限る必要はなく液剤であっても良い。また具体
的な液剤としては、アミノ酸の一種であるグルタミン酸
がある。特に、グルタミン酸水溶液を100℃に加熱す
ると一部ヒロリドン化し変質してしまうので、高圧蒸気
滅菌ができない。このように水溶液の状態で滅菌できな
い薬剤も対象となる。
The drug container 5 is a glass vial. However, it is not necessary to use glass as in the present embodiment, and the material thereof may be a resin molded product having a composition of low density polyethylene, high density polyethylene, polypropylene or the like.
The drug 6 as the second component is freeze-dried in the drug container 5,
It is aseptically filled and the mouth is tightly closed with the rubber stopper 7 to be maintained aseptically. In this embodiment, the second component drug 6 is a powdered anti-substance substance. However, in this embodiment, the drug 7
The powder need not be limited to powder and may be a liquid agent. A specific liquid agent is glutamic acid, which is a type of amino acid. Particularly, when the aqueous solution of glutamic acid is heated to 100 ° C., it is partially converted into hirolidone and deteriorates, so that high-pressure steam sterilization cannot be performed. Drugs that cannot be sterilized in the state of an aqueous solution are also targeted.

【0019】本実施例に係るホルダー1は、収容部材1
1と蓋体12とからなり、収容部材11内には弾性部材
であるゴム緩衝部材13が配せられる。図2及び図4に
示す如く、収容部材11は樹脂成形物で、大径な薬剤バ
イアル5の収容部内に連通する小径な接続部15を有し
た筒部材である。収容部と接続部15との間の連通口1
4には緩衝部材13が配され、また接続部15は上述の
接続口パイプ4Aのスリーブ部分に液密に嵌着される。
緩衝部材13の中央部には連通路16が形成され、連通
路16は接続部15内と連通される。収容部材11内に
は、口部を挿入端として薬剤バイアル5が挿入配置さ
れ、薬剤容器5の配置後、収容部材11の接合開口端に
蓋体12が係着により取り付けられる。
The holder 1 according to the present embodiment includes a housing member 1
1 and a lid 12, and a rubber cushioning member 13 which is an elastic member is arranged in the containing member 11. As shown in FIGS. 2 and 4, the housing member 11 is a resin molded product, and is a tubular member having a small-diameter connecting portion 15 communicating with the housing portion of the large-diameter drug vial 5. Communication port 1 between the housing part and the connection part 15
A buffer member 13 is arranged at 4, and the connecting portion 15 is liquid-tightly fitted to the sleeve portion of the above-mentioned connecting port pipe 4A.
A communication passage 16 is formed in the center of the cushioning member 13, and the communication passage 16 communicates with the inside of the connection portion 15. The medicine vial 5 is inserted and arranged in the housing member 11 with the mouth portion as an insertion end, and after the medicine container 5 is arranged, the lid 12 is attached to the joint opening end of the housing member 11 by fastening.

【0020】図3及び図4に示す如く、収容部材11の
接合端にはフランジ17が形成され、フランジ17の所
定の4カ所には、係合孔18、18、18、18が形成
される。一方、蓋体12はほぼキャップ状に形成され、
その接合端にはフランジ19が形成され、フランジ19
の所定の4カ所には、係合孔18に嵌合する突起部2
0、20、20、20が形成される。突起部20は首状
の付け根形成され、一旦、係合孔18に嵌合すると破壊
しない限り係脱不可となっている。また、蓋体12は、
薬剤容器5を介して緩衝部材13を押圧して収容部材1
1に係着され、緩衝部材13は圧縮されて連通口14の
周縁とゴム栓体7の外表面を弾性力で付勢している。こ
のため、接続部15内は、ゴム栓体7と緩衝部材13に
よって液密に維持される。そして、図1に示す如く、接
続部15の開口は、緩衝部材13と容器5のゴム栓体7
で覆われた状態となっている。収容部材11と蓋体12
の取り付け機構は、上記実施例に限ることはない。例え
ば、互いに螺合する雄螺子と雌捻子とを刻設した取り付
け構造であっても良い。但し、収容部材11及び蓋体1
2を透明な樹脂成形物とした場合は、薬剤6の混合状態
が十分に確認できるような簡単な係着機構であることが
望ましい。また、本実施例では、係合部を係合孔18と
したが、嵌合溝であっても良く、簡単に係着させて組み
立てることができる限り、本実施例に限ることはなく、
またその樹脂の射出成形上、好ましい係合部であれば問
題はない。
As shown in FIGS. 3 and 4, a flange 17 is formed at the joint end of the accommodating member 11, and engaging holes 18, 18, 18, 18 are formed at four predetermined positions of the flange 17. . On the other hand, the lid 12 is formed in a substantially cap shape,
A flange 19 is formed at the joint end, and the flange 19
At the predetermined four positions of the
0, 20, 20, 20 are formed. The protrusion 20 has a neck-shaped base, and once fitted into the engagement hole 18, it cannot be engaged or disengaged unless it is broken. Also, the lid 12 is
The buffer member 13 is pressed through the medicine container 5 to receive the containing member 1
1, the cushioning member 13 is compressed and urges the peripheral edge of the communication port 14 and the outer surface of the rubber plug 7 with elastic force. Therefore, the inside of the connection portion 15 is kept liquid-tight by the rubber stopper 7 and the buffer member 13. Then, as shown in FIG. 1, the opening of the connecting portion 15 is provided with the cushioning member 13 and the rubber stopper 7 of the container 5.
It is covered with. Housing member 11 and lid 12
The mounting mechanism is not limited to the above embodiment. For example, it may be a mounting structure in which a male screw and a female screw that are screwed together are engraved. However, the housing member 11 and the lid 1
When 2 is a transparent resin molded product, it is desirable that the engagement mechanism be simple so that the mixed state of the drug 6 can be sufficiently confirmed. Further, although the engaging portion is the engaging hole 18 in the present embodiment, it may be a fitting groove and is not limited to this embodiment as long as it can be easily engaged and assembled.
There is no problem in the injection molding of the resin as long as it is a preferable engaging portion.

【0021】図3に示す如く、薬剤容器5の押圧面であ
る蓋体12の底壁には突起リブ21が形成され、突起リ
ブ21は、薬剤容器5の寸法に応じて所定の高さに形成
される。突起リブ21は、少なくとも0.5mm以上、
特に0.5〜10mmの範囲にあることが望ましい。突
起リブ21は薬剤容器5の寸法調整になると共に、ある
程度、押圧面に局部的な反力をかけるため押圧面を容易
に歪め、またそれ自身が多少の屈曲を生じるので、薬剤
容器5の寸法に微妙な誤差を生じても、緩衝部材13に
過大な押圧がかかったり、或いは全く押圧力がかからな
かったりすることを防止する。また、蓋体12の外側に
は折り畳み式の吊り部22が形成され、吊り部22には
吊り孔23が設けられる。
As shown in FIG. 3, a protruding rib 21 is formed on the bottom wall of the lid 12 which is the pressing surface of the medicine container 5, and the protruding rib 21 has a predetermined height according to the size of the medicine container 5. It is formed. The protruding rib 21 is at least 0.5 mm or more,
Particularly, it is desirable that it is in the range of 0.5 to 10 mm. The projection rib 21 adjusts the size of the medicine container 5, and locally applies a local reaction force to the pressing surface to some extent, so that the pressing surface is easily distorted and the bending itself occurs to some extent. Even if a slight error occurs, it is prevented that the buffer member 13 is excessively pressed or no pressing force is applied. A foldable hanging portion 22 is formed outside the lid 12, and a hanging hole 23 is provided in the hanging portion 22.

【0022】蓋体12は、ポリエチレン系樹脂成形物で
あり、その樹脂は、引張強さ(JISK6760法:kg
f/cm2)が300kgf/cm2以下、特に250kgf/cm2以下
の範囲にあることが望ましい。またその樹脂は、引張破
壊伸び(JISK6760法:%)が90〜1000
%、特に200〜900%の範囲であることが望まし
い。 このような樹脂を蓋体12に用いると、蓋体12
の押圧面が緩衝部材13からの反力を曲げ変形により吸
収することができるため、薬剤容器5の寸法に微妙な誤
差を生じても、緩衝部材13に過大な押圧がかかった
り、或いは全く押圧力がかからなかったりすることはな
い。このため、蓋体12のポリエチレン系樹脂成形物の
引張強さが上記範囲を上回り、蓋体の押圧面に過大な反
力がかかると、組立作業上、蓋体12は収容部材11に
容易に取り付けることができず、また組立生産ラインに
おいても歩留まりを悪くする。また引張破壊伸びが上記
範囲を下回ると、曲げ変形状態での蓋体12の破損のお
それが大きくなる。また、ポリエチレン系樹脂のメルト
インデックスは、1〜70g/10min、特に3〜4
0g/10minであることが望ましい。かかる範囲内
にあれば、蓋体としての成形物の成形性が良く、成形物
に支障が生じない。ポリエチレン系樹脂は、具体的に
低、高密度ポリエチレン樹脂、直鎖状低密度ポリエチレ
ン樹脂等であり、またこれらのエチレン系樹脂を主体と
したブレンド物、例えば、酢酸ビニル等の他の樹脂の共
重合体とのブレンド物でも良い。
The lid 12 is a polyethylene resin molding, and the resin has a tensile strength (JIS K6760 method: kg).
f / cm 2 ) is preferably 300 kgf / cm 2 or less, and particularly preferably 250 kgf / cm 2 or less. Moreover, the resin has a tensile elongation at break (JIS K 6760 method:%) of 90 to 1000.
%, Particularly preferably in the range of 200 to 900%. When such a resin is used for the lid 12, the lid 12
Since the pressing surface of the buffer member can absorb the reaction force from the buffer member 13 by bending deformation, even if a slight error occurs in the size of the medicine container 5, the buffer member 13 is pressed excessively or is not pressed at all. There is no need to apply pressure. Therefore, when the tensile strength of the polyethylene resin molded product of the lid 12 exceeds the above range and an excessive reaction force is applied to the pressing surface of the lid 12, the lid 12 is easily attached to the housing member 11 during assembly work. It cannot be attached, and the yield is deteriorated in the assembly production line. If the tensile elongation at break is less than the above range, the lid 12 is more likely to be damaged in the bending deformation state. The melt index of polyethylene resin is 1 to 70 g / 10 min, especially 3 to 4
It is preferably 0 g / 10 min. Within such a range, the moldability of the molded product as the lid is good, and the molded product is not hindered. The polyethylene-based resin is specifically a low- or high-density polyethylene resin, a linear low-density polyethylene resin, or the like, and a blend containing these ethylene-based resins as a main component, for example, a copolymer of other resins such as vinyl acetate. It may be a blend with a polymer.

【0023】収容部材11は、汎用樹脂の成形物でも良
いが、好ましくは上記蓋体12と同様な樹脂であること
が好ましい。また、蓋体12及び収容部材11は、透明
成形物であることが望ましい、ある程度の透明性を有す
れば、薬剤容器5内の薬剤6の混合状態を容易に知るこ
とができる。弾性緩衝部材13は、ゴム材からなる成形
物である。緩衝部材13の厚みはゴム材の弾性にもよる
が、好ましくは30mm以下、特に10mm以下3mm
以上であることが好ましい。本実施例ではゴム材を使用
しているが、弾性を有する部材であれば、かかる材に限
ることはなく、例えば熱可塑性エラストマー等であって
も良い。また、本実施例では、連通口14での弾性力を
高めるために緩衝部材13を使用したが、薬剤バイアル
5のゴム栓体7が十分な弾性力と機密性を有していれ
ば、緩衝部材13はなくても良い。
The housing member 11 may be a general-purpose resin molding, but is preferably the same resin as the lid 12. Further, it is desirable that the lid 12 and the containing member 11 are transparent molded products. If they have a certain degree of transparency, the mixed state of the drug 6 in the drug container 5 can be easily known. The elastic cushioning member 13 is a molded product made of a rubber material. Although the thickness of the cushioning member 13 depends on the elasticity of the rubber material, it is preferably 30 mm or less, particularly 10 mm or less 3 mm.
It is preferable that it is above. Although a rubber material is used in this embodiment, the material is not limited to such a material as long as it has elasticity, and may be, for example, a thermoplastic elastomer. Further, in the present embodiment, the cushioning member 13 is used to increase the elastic force at the communication port 14, but if the rubber stopper 7 of the drug vial 5 has sufficient elastic force and airtightness, the cushioning member 13 is used. The member 13 may be omitted.

【0024】このように構成されたホルダー1にあって
は、弾性緩衝部材13が収容部材11内の連通口14に
配され、次に薬剤バイアル5が配される。そして、蓋体
12で薬剤バイアル5の底部が押圧され、蓋体12の突
起部20が収容部材11の係合孔18に押し込まれ、突
起部20の首部が係合孔18の周縁に係止される。これ
により、蓋体12は緩衝部材13を押圧した状態で収容
部材11に取り付けられる。この場合、緩衝部材13の
弾性力により、接続部15の内壁と緩衝部材13の外壁
との間が隙間無く密封され、ゴム栓体7と緩衝部材13
の外壁との間が隙間無く密封される。そして、連通針4
Bが移動する緩衝部材13の連通路16内は、密封され
た状態に維持されるため、長期間無菌的に維持すること
が可能となる。また、収容部材11の全体を滅菌する必
要がなく、接続部15内の滅菌に限られるため、γ線、
電子線等の照射滅菌、過酸化水素水による化学滅菌等の
多様な滅菌処理が何等問題なくすることができる。
In the holder 1 thus constructed, the elastic cushioning member 13 is arranged in the communication port 14 in the containing member 11, and then the drug vial 5 is arranged. Then, the bottom of the drug vial 5 is pressed by the lid 12, the projection 20 of the lid 12 is pushed into the engagement hole 18 of the housing member 11, and the neck of the projection 20 is locked to the peripheral edge of the engagement hole 18. To be done. As a result, the lid 12 is attached to the housing member 11 with the cushioning member 13 pressed. In this case, due to the elastic force of the cushioning member 13, the inner wall of the connecting portion 15 and the outer wall of the cushioning member 13 are tightly sealed, and the rubber plug 7 and the cushioning member 13 are sealed.
There is no gap between the outer wall and the outer wall. And communication needle 4
Since the inside of the communication passage 16 of the buffer member 13 in which B moves is maintained in a sealed state, it is possible to maintain the condition aseptically for a long period of time. Moreover, since it is not necessary to sterilize the entire housing member 11 and the sterilization is limited to the inside of the connection portion 15, γ rays,
Various sterilization treatments such as irradiation sterilization with electron beams and chemical sterilization with hydrogen peroxide can be done without any problems.

【0025】また、ホルダー1の収容部材11と蓋体1
2が係合孔18及び突起部20の係着により取り付けら
れると、収容部材11及び蓋体12は複雑な形状が要求
されないため、全体を透明材で成形すれば、薬剤バイア
ル5内の薬剤6の混合状態が容易に確認できる。更に、
蓋体12の成形樹脂に上記特性を有するものを使用すれ
ば、通常、寸法等にかなりな誤差を生じる薬剤バイアル
5に適用する場合でも、接続部15内の長期間の無菌的
維持が全てのロットに維持され、その一方、生産組立ラ
インにおける取り付け失敗等による歩留まりの減少がみ
られない。また、突起リブを形成したことにより、良品
の生産組立が更に良くなり、寸法調整も容易にできる。
The housing member 11 of the holder 1 and the lid 1
When 2 is attached by engaging the engaging hole 18 and the protrusion 20, the housing member 11 and the lid 12 are not required to have a complicated shape. Therefore, if the whole is molded with a transparent material, the drug 6 in the drug vial 5 can be formed. The mixed state of can be easily confirmed. Furthermore,
By using a molding resin having the above-mentioned characteristics as the molding resin of the lid body 12, even when it is applied to the drug vial 5 that usually causes a considerable error in dimensions, it is possible to maintain the sterility in the connection portion 15 for a long time. It is maintained in a lot, but on the other hand, there is no decrease in yield due to installation failure in the production assembly line. Further, by forming the protruding ribs, the production and assembly of non-defective products can be further improved, and the dimensional adjustment can be facilitated.

【0026】尚、医療用容器2を使用する際には、先
ず、容器2の外側から連通針4Bを操作し、図5に示す
如くスリーブ部分の薄肉膜41及びゴム栓7に突き刺し
て、連通針4Bの中空部及び流通口46を介して容器2
と、薬剤バイアル5とを連通する。これにより、溶解液
3がポンピング等により一部薬剤バイアル5側に流入さ
れ薬剤6と混合する。完全に混合後、容器2に戻し、排
出口に連通針等を刺針して患者に混合薬剤を投与する。
When the medical container 2 is used, first, the communicating needle 4B is operated from the outside of the container 2 to pierce the thin film 41 and the rubber stopper 7 of the sleeve portion to communicate with each other, as shown in FIG. The container 2 is inserted through the hollow portion of the needle 4B and the flow port 46.
And the drug vial 5 are communicated with each other. As a result, the solution 3 is partially flown into the drug vial 5 side by pumping or the like and mixed with the drug 6. After mixing completely, the mixture is returned to the container 2 and a communicating needle or the like is inserted into the discharge port to administer the mixed drug to the patient.

【0027】・性能評価 上記実施例において、容器2に溶解液の代わりに、以下
の2種類の培地A、Bを充填して、かかる容器2を高圧
蒸気滅菌すると共に、薬剤バイアル5を空にして内部を
滅菌した後、容器2と薬剤バイアル5と過酸化水素水に
より滅菌して接続した。そしてかかる医療用容器2を1
00個製造した。尚、ホルダー1の組立に際しては組立
不良を全く起こさなかった。医療用容器2と薬剤バイア
ル5を連通し一旦、薬剤バイアル5側に入れて、これを
戻した後、1週間、医療用容器2及びホルダー1の全体
を培地にドブ付けして、その後、一ヶ月間観察した。1
00個の全てに、菌は繁殖しなかった。 A培地:チオグリコール酸培地II(32℃、7日間培
養) B培地:ブドウ糖・ペプトン培地(24℃、7日間培
養)
Performance Evaluation In the above example, the following two types of culture media A and B were filled in the container 2 instead of the solution, and the container 2 was sterilized by high pressure steam and the drug vial 5 was emptied. After sterilizing the inside by sterilization, the container 2, the drug vial 5 and the hydrogen peroxide solution were sterilized and connected. And one such medical container 2
00 pieces were produced. When assembling the holder 1, no assembly failure occurred. The medical container 2 and the drug vial 5 are communicated with each other, and once put in the drug vial 5 side and then returned, the entire medical container 2 and the holder 1 are dipped into the medium for one week, and then, Observed for a month. 1
The fungus did not propagate to all 00. A medium: Thioglycolic acid medium II (32 ° C., 7 days culture) B medium: glucose / peptone medium (24 ° C., 7 days culture)

【0028】図6は、本発明に係る医療用容器に接続さ
れる薬剤容器のホルダーの第二実施例を示す図である。
図6に示すホルダー51は、第一実施例のホルダーほぼ
同様な構成になっており、同様な部分、又は部材につい
ては図1と同一の符号を付してその詳しい説明を省略す
るが、第一実施例のホルダー1と異なる点は以下の点で
ある。ホルダー51の蓋体53は、第一実施例の蓋体1
2と同様な樹脂による成形物であるが、突起リブ21等
を有しておらず、蓋体12はキャップ状でその側壁53
Aがテーパに形成されている。蓋体53は接合開口から
奥に向かうに従って小径に形成され、側壁5が薬剤バイ
アル5の底部の周縁に当接する。薬剤バイアル5の挿入
方向に対する側壁のテーパ角度は2〜45度、好ましく
は3〜30度である。かかる範囲内にあると、側壁5面
が折り曲がった状態で薬剤バイアル5に当接することか
ら、薬剤バイアル5の長さに多少のばらつきがあっても
底部を確実に当接押圧するとともに、係合部の係合孔1
8と突起部20との係着が簡単にできる。従って、生産
組立が更に向上することとなる。尚、上記実施例では、
側壁53Aをテーパ状としたが、上記作用効果を生じる
限り側壁53Aにテーパ状に形成される突起リブを設け
ても良い。
FIG. 6 is a view showing a second embodiment of the holder of the medicine container connected to the medical container according to the present invention.
The holder 51 shown in FIG. 6 has substantially the same structure as the holder of the first embodiment. Similar parts or members are designated by the same reference numerals as those in FIG. 1 and their detailed description is omitted. The following points are different from the holder 1 of the embodiment. The lid 53 of the holder 51 is the lid 1 of the first embodiment.
Although it is a molded product made of the same resin as that of No. 2, it does not have the protruding ribs 21 and the like, and the lid 12 is a cap-shaped side wall 53
A is tapered. The lid 53 is formed so as to have a smaller diameter from the joint opening toward the inner side, and the side wall 5 contacts the peripheral edge of the bottom portion of the drug vial 5. The taper angle of the side wall with respect to the inserting direction of the drug vial 5 is 2 to 45 degrees, preferably 3 to 30 degrees. Within such a range, the side wall 5 comes into contact with the drug vial 5 in a bent state. Therefore, even if there is some variation in the length of the drug vial, the bottom part is reliably brought into contact and pressed, and Engagement hole 1 at the joint
8 and the protrusion 20 can be easily engaged with each other. Therefore, production and assembly will be further improved. In the above embodiment,
Although the sidewall 53A is tapered, the sidewall 53A may be provided with a protruding rib that is tapered as long as the above-described effects are produced.

【0029】上記各実施例では、医療用容器の接続口4
の構造を容器本体内に連通針を備えるものとしたが、接
続口4はこれに限る必要はなく、接続口がホルダー1、
51の接続部と無菌的に接続されるものである限り、本
発明に係るホルダーに適用することができる。
In each of the above embodiments, the connection port 4 of the medical container is used.
However, the connection port 4 is not limited to this, and the connection port is not limited to this.
As long as it is aseptically connected to the connecting portion 51, it can be applied to the holder according to the present invention.

【0030】[0030]

【発明の効果】以上説明したように本発明の医療用容器
に接続されるホルダーは、上記薬剤容器を収容する収容
部内に連通して、内部が無菌的に維持される上記接続部
を有した収容部材と、上記収容部材に取り付けられ、上
記収容部と接続部との連通口を上記薬剤容器の口部用弾
性栓体で、或いは弾性部材を介して覆っている該薬剤容
器を該栓体或いは弾性部材に向けて押圧する蓋体とから
なるので、接続部での滅菌が多様且つ簡単にでき、また
接続部の長期間の無菌的維持ができると共に、組立が簡
単にできる。
As described above, the holder connected to the medical container of the present invention has the above-mentioned connecting portion that communicates with the inside of the containing portion for containing the above-mentioned drug container and maintains the inside aseptically. An accommodating member, which is attached to the accommodating member and covers the communication port between the accommodating portion and the connecting portion with an elastic stopper for the mouth of the medicine container, or the medicine container covered with an elastic member. Alternatively, since it comprises a lid body that is pressed against the elastic member, sterilization at the connection portion can be performed in various ways and easily, and the connection portion can be maintained aseptic for a long period of time, and the assembly can be facilitated.

【図面の簡単な説明】[Brief description of drawings]

【図1】本発明に係るホルダーの第一実施例の半断面図
である。
FIG. 1 is a half sectional view of a first embodiment of a holder according to the present invention.

【図2】第一実施例の分解側面図である。FIG. 2 is an exploded side view of the first embodiment.

【図3】第一実施例のホルダーにおける蓋体の接合面の
平面図である。
FIG. 3 is a plan view of a joint surface of a lid body in the holder of the first embodiment.

【図4】第一実施例のホルダーにおける収容部材の接合
面の平面図である。
FIG. 4 is a plan view of a joint surface of a housing member in the holder of the first embodiment.

【図5】第一実施例における医療用容器の使用中の要部
の半断面図である。
FIG. 5 is a half cross-sectional view of a main part of the medical container according to the first embodiment during use.

【図6】本発明に係るホルダーの第二実施例の半断面図
である。
FIG. 6 is a half sectional view of a second embodiment of the holder according to the present invention.

【図7】従来のホルダーの断面図である。FIG. 7 is a cross-sectional view of a conventional holder.

【符号の説明】[Explanation of symbols]

1 ホルダー 2 医療用容器 2A 上端シール部 3 溶解液(投与剤) 4 接続口 5 薬剤バイアル 6 薬剤 7 ゴム栓体 11 収容部材 12 蓋体 13 弾性緩衝部材 14 連通口 15 接続部 16 連通路 17 接合面フランジ 18 係合孔 20 突起部 21 突起リブ DESCRIPTION OF SYMBOLS 1 Holder 2 Medical container 2A Upper end seal part 3 Dissolution liquid (administration agent) 4 Connection port 5 Drug vial 6 Drug 7 Rubber stopper 11 Storage member 12 Lid body 13 Elastic buffer member 14 Communication port 15 Connection part 16 Communication path 17 Joining Face flange 18 Engagement hole 20 Projection 21 Projection rib

Claims (7)

【特許請求の範囲】[Claims] 【請求項1】 医療用容器に接続される接続部を有し、
且つ該医療容器内と連通接続される薬剤容器を保持する
ホルダーにおいて、 上記薬剤容器を収容する収容部内に連通して、内部が無
菌的に維持される上記接続部を有した収容部材と、 上記収容部材に取り付けられ、上記収容部と接続部との
連通口を上記薬剤容器の口部用弾性栓体で、或いは弾性
部材を介して覆っている該薬剤容器を該栓体或いは弾性
部材に向けて押圧する蓋体とからなることを特徴とする
医療用容器に接続される薬剤容器のホルダー。
1. A connecting part connected to a medical container,
And, in a holder for holding a drug container that is communicatively connected to the inside of the medical container, a container member that is in communication with the container part that houses the drug container and has the connection part that maintains the inside of the container aseptically, The drug container, which is attached to the container member and covers the communication port between the container part and the connection part with an elastic stopper for the mouth of the drug container, or directs the drug container toward the plug member or the elastic member via the elastic member. A holder for a drug container to be connected to a medical container, characterized in that it comprises a lid body that is pressed against.
【請求項2】 上記収容部材と蓋体とには互いに係合す
る係合部が形成され、該係合部の係合により上記蓋体が
上記薬剤容器を押圧して上記収容部材に係着して取り付
けられることを特徴とする請求項1記載のホルダー。
2. An engaging portion that engages with each other is formed on the accommodating member and the lid, and the engaging of the engaging portion causes the lid to press the drug container to engage with the accommodating member. The holder according to claim 1, wherein the holder is attached.
【請求項3】 上記収容部材及び蓋体は、上記薬剤容器
内の薬剤の認識可能な透明樹脂成形物であることを特徴
とする請求項2記載のホルダー。
3. The holder according to claim 2, wherein the accommodating member and the lid are transparent resin moldings capable of recognizing the medicine in the medicine container.
【請求項4】 上記蓋体は、ポリエチレン系樹脂成形物
からなり、該樹脂の引張強さ(JISK6760法:kg
f/cm2)が300kgf/cm2以下、引張破壊伸び(JISK
6760法:%)が90〜1000%の範囲であること
を特徴とする請求項1〜3の何れかに記載のホルダー。
4. The lid is made of a polyethylene resin molded product, and has a tensile strength (JIS K6760 method: kg).
f / cm 2 ) is less than 300 kgf / cm 2 , tensile elongation at break (JISK
6760 method:%) is in the range of 90 to 1000%, The holder according to claim 1.
【請求項5】 上記薬剤容器を押圧する押圧面には突起
リブが形成されることを特徴とする請求項1〜4の何れ
かに記載のホルダー。
5. The holder according to claim 1, wherein a protruding rib is formed on a pressing surface that presses the medicine container.
【請求項6】 上記蓋体の側壁がテーパ形成され、上記
薬剤容器の底部の周縁が該テーパ側壁と当接して押圧さ
れた状態で配されていることを特徴とする請求項1〜4
の何れかに記載のホルダー。
6. The side wall of the lid body is formed in a taper shape, and the peripheral edge of the bottom portion of the medicine container is arranged in a state of being pressed against the tapered side wall.
Holder according to any one of.
【請求項7】 上記蓋体の側壁にはテーパ状の突起リブ
が形成され、上記薬剤容器の底部の周縁が該突起リブと
当接して押圧された状態で配されていることを特徴とす
る請求項1〜4の何れかに記載のホルダー。
7. A tapered protrusion rib is formed on a side wall of the lid, and a peripheral edge of a bottom portion of the drug container is arranged in a state of being pressed against the protrusion rib. The holder according to any one of claims 1 to 4.
JP7203862A 1995-07-17 1995-07-17 Holder for medicine container connected to medical container Pending JPH0928762A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP7203862A JPH0928762A (en) 1995-07-17 1995-07-17 Holder for medicine container connected to medical container

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7203862A JPH0928762A (en) 1995-07-17 1995-07-17 Holder for medicine container connected to medical container

Publications (1)

Publication Number Publication Date
JPH0928762A true JPH0928762A (en) 1997-02-04

Family

ID=16480939

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7203862A Pending JPH0928762A (en) 1995-07-17 1995-07-17 Holder for medicine container connected to medical container

Country Status (1)

Country Link
JP (1) JPH0928762A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021040952A (en) * 2019-09-11 2021-03-18 株式会社リブドゥコーポレーション Medical needle holder
JP2025111834A (en) * 2020-06-25 2025-07-30 バード・ペリフェラル・バスキュラー・インコーポレーテッド Vial geometries for optimal mixing

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021040952A (en) * 2019-09-11 2021-03-18 株式会社リブドゥコーポレーション Medical needle holder
JP2025111834A (en) * 2020-06-25 2025-07-30 バード・ペリフェラル・バスキュラー・インコーポレーテッド Vial geometries for optimal mixing

Similar Documents

Publication Publication Date Title
EP0554988B1 (en) Mixing apparatus
JP5283417B2 (en) Cap and prefilled syringe manufacturing method
JPH021277A (en) infusion container
SK2382001A3 (en) Container for intravenous administration
US5382406A (en) Sterile filling method
JP4477216B2 (en) Cap, method of manufacturing the same, and drug container using the cap
US7115117B2 (en) Infusion vessel
JPH0928762A (en) Holder for medicine container connected to medical container
JPH1147273A (en) Medicinal liquid injection utensil
JPH0928763A (en) Holder for medicine container
JP4381614B2 (en) Manufacturing method of prefilled syringe
JP2003111819A (en) Sealed body, chemical solution container cap using the same, and chemical solution container
JP2001025506A (en) Medicinal liquid-containing syringe
JP2002177388A (en) Prefilled syringes for pharmaceutical and medical use
JP4366131B2 (en) Multi-chamber container
JP4491215B2 (en) Prefilled syringe and method for producing prefilled syringe
WO2002072175A1 (en) Chemical liquid injection port, and chemical liquid container having the same
JP4010890B2 (en) Syringe
JPH0910283A (en) Container for medical treatment with juncture for easy sterilization
JP3634560B2 (en) Filled chemical container
JPH0919480A (en) Medical vessel
JPH09276370A (en) Medical container and manufacturing method thereof
JPH09108302A (en) Medical container and its manufacture
JPH09248328A (en) Medical container and manufacturing method thereof
JPH11104213A (en) Cap for medicine container